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Abstract
Background  and  objectives: The  use  of  neuraxial  anesthesia  in  cardiac  surgery  is  recent,  but
the hemodynamic  effects  of  local  anesthetics  and  anticoagulation  can  result  in  risk  to  patients.
Objective:  To  review  the  beneﬁts  of  neuraxial  anesthesia  in  cardiac  surgery  for  CABG  through
a systematic  review  of  systematic  reviews.
Content:  The  search  was  performed  in  Pubmed  (January  1966  to  December  2012),  Embase  (1974
to December  2012),  The  Cochrane  Library  (volume  10,  2012)  and  Lilacs  (1982  to  December
2012) databases,  in  search  of  articles  of  systematic  reviews.  The  following  variables:  mortality,
myocardial  infarction,  stroke,  in-hospital  length  of  stay,  arrhythmias  and  epidural  hematoma
were analyzed.
Conclusions:  The  use  of  neuraxial  anesthesia  in  cardiac  surgery  remains  controversial.  The
greatest beneﬁt  found  by  this  review  was  the  possibility  of  reducing  postoperative  arrhyth-
mias, but  this  result  was  contradictory  among  the  identiﬁed  ﬁndings.  The  results  of  ﬁndings
regarding mortality,  myocardial  infarction,  stroke  and  in-hospital  length  of  stay  did  not  show
greater efﬁcacy  of  neuraxial  anesthesia.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved. Study conducted at Universidade Federal de Alagoas, Maceió, AL, Brazil.
∗ Corresponding author.
E-mail: fabianotimbo@yahoo.com.br (F.T. Barbosa).
ttp://dx.doi.org/10.1016/j.bjane.2013.09.015
104-0014/© 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.
Is  there  any  beneﬁt  in  associating  neuraxial  anesthesia  to  general  anesthesia?  305
PALAVRAS-CHAVE
Anestesia  geral;
Anestesia
subaracnoidea;
Anestesia  epidural
torácica;
Revisão  sistemática;
Mortalidade;
Evidências
Existe  algum  benefício  em  associar  a  anestesia  neuroaxial  à  anestesia  geral  para
revascularizac¸ão  miocárdica?
Resumo
Justiﬁcativa  e  objetivos:  O  uso  da  anestesia  neuroaxial  em  cirurgia  cardíaca  é  recente,  porém
os efeitos  hemodinâmicos  dos  anestésicos  locais  e  a  anticoagulac¸ão  podem  trazer  riscos  aos
pacientes.
Objetivo: Revisar  os  benefícios  da  anestesia  neuroaxial  em  cirurgia  cardíaca  para
revascularizac¸ão miocárdica  por  meio  de  uma  revisão  sistemática  de  revisões  sistemáticas.
Conteúdo:  Foi  feita  pesquisa  nas  bases  de  dados  Pubmed  (de  janeiro  de  1966  a  dezembro  de
2012), Embase  (1974  a  dezembro  2012),  The  Cochrane  Library  (volume  10,  2012)  e  Lilacs  (1982  a
dezembro  de  2012)  em  busca  de  artigos  de  revisões  sistemáticas.  Foram  analisadas  as  seguintes
variáveis:  mortalidade,  infarto  do  miocárdio,  acidente  vascular  cerebral,  tempo  de  internac¸ão
hospitalar,  arritmias  e  hematoma  peridural.
Conclusões:  O  uso  da  anestesia  neuroaxial  para  revascularizac¸ão  miocárdica  permanece  con-
troverso. O  maior  benefício  encontrado  por  meio  desta  revisão  foi  a  possibilidade  de  reduc¸ão
das arritmias  pós-operatórias,  porém  esse  resultado  foi  contraditório  entre  as  evidências  iden-
tiﬁcadas. Os  resultados  das  evidências  encontradas  referentes  à  mortalidade,  ao  infarto  do
miocárdio,  ao  acidente  vascular  cerebral  e  ao  tempo  de  internac¸ão  hospitalar  não  mostraram
maior efetividade  da  anestesia  neuroaxial.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
M
T
t
a
r
r
r
n
n
w
p
s
D
C
D
i
w
o
c
d
C
w
T
(
rIntroduction
The  technological  and  pharmacological  advances  in  anes-
thesia  and  surgery  over  the  past  decades,  as  well  as
better  working  conditions  in  intensive  care  units  decreased
complications  in  patients  undergoing  cardiac  surgery.1,2
Neuraxial  anesthesia  (NA)  causes  sympathectomy  and
can  improve  the  coronary  perfusion  and  balance  between
supply  and  demand  of  myocardial  oxygen  and  reduce  the
incidence  of  postoperative  arrhythmias  and  perioperative
heart  attack.3--5 The  combination  of  general  anesthesia  (GA)
and  NA  may  bring  beneﬁts  to  patients  undergoing  cardiac
surgery.3,4
The  systematic  use  of  anticoagulation  in  cardiac  surgery
with  cardiopulmonary  bypass  increases  the  risk  of  hematoma
and  spinal  cord  compression  when  anesthesia  is  performed
on  spinal  cord  or  nerves.6 The  major  problem  with  neuraxial
administration  of  local  anesthetics  is  systemic  hypoten-
sion,  which  may  be  accompanied  by  decreases  in  coronary
blood  ﬂow,  as  the  safe  level  of  hypotension  in  patients
undergoing  cardiac  surgery  is  not  known.7 If  we  take
into  account  the  physiological  effects  of  local  anesthetic
neuraxial  administration  and  NA  management  in  patients
with  anticoagulation,  it  is  noticed  that  the  use  of  NA,
i.e.,  thoracic  epidural  anesthesia  (TEA)  and  spinal  anes-
thesia  (SA),  in  cardiac  surgery  remains  controversial.6,7
It  is  necessary  to  analyze  the  existing  data  in  the  lit-
erature  to  identify  beneﬁts  of  the  NA  administration
in  cardiac  surgery  for  coronary  artery  bypass  grafting
(CABG).
The  aim  of  this  article  was  to  review  the  NA  beneﬁts
in  cardiac  surgery  for  CABG  through  a  systematic  review  of
systematic  reviews.
s
w
wethods
he  strategy  to  accomplish  this  systematic  review  followed
he  Cochrane  Collaboration  guidelines.8 This  is  a  system-
tic  review  of  systematic  reviews.  The  items  for  systematic
eviews  publications  of  Prisma  statement  were  followed  to
eport  the  results  of  this  review.9
Inclusion  criteria  were  systematic  review  articles  of
andomized  controlled  trials  (RCTs)  evaluating  the  use  of
euraxial  anesthesia  in  cardiac  surgery  for  CABG.  There  was
o  language  restriction.  Other  types  of  research  articles
ere  excluded  from  the  analysis.
The  identiﬁcation  of  systematic  review  articles  was
erformed  by  searching  in  electronic  databases.  The
ources  used  were:  Medline  via  PubMed  (January  1966  to
ecember  2012),  Embase  (1974  to  December  2012),  The
ochrane  Library  (volume  10,  2012),  and  Lilacs  (1982  to
ecember  2012).  The  search  strategy  used  for  PubMed
s  shown  in  Table  1.  The  search  strategy  for  Embase
as:  systematic  review/exp  and  general  anesthesia/exp
r  spinal  anesthesia/exp  or  epidural  anesthesia/exp  and
ardiac  surgery/exp  and  embase/lim.  ‘Anesthesia’  and  ‘car-
iac  surgery’  terms  were  used  for  Lilacs  and  Cochrane
ollaboration.
The  published  articles  identiﬁed  by  the  search  strategy
ere  selected  by  analysis  of  titles  and  abstracts,  or  both.
his  selection  was  independently  made  by  two  reviewers
Barbosa  F.T.  and  Castro  A.A.)  and  followed  by  meetings  to
esolve  disagreements  between  the  authors.  The  published
ystematic  review  articles  that  met  the  inclusion  criteria
ere  fully  reviewed.
The  Overview  Quality  Assessment  Questionnaire  (OQAQ)
as  used  to  assess  the  quality  of  systematic  reviews  with
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Table  1  Search  strategy  for  Medline  via  Pubmed.
Database  Terms  used
Pubmed  systematic[sb]
and
thoracic  surgery  [Mesh  Terms]  or  (thoracic
[all ﬁelds]  and  surgery  [all  ﬁelds])  or
thoracic  surgery  [all  ﬁelds]  or  (cardiac  [all
ﬁelds]and  surgery  [all  ﬁelds])  or  cardiac
surgery  [all  ﬁelds]  or  cardiac  surgical
procedures  [Mesh  Terms]  or  (cardiac  [all
ﬁelds]  and  surgical  [all  ﬁelds]  and
procedures  [all  ﬁelds])  or  cardiac  surgical
procedures  [all  ﬁelds]  or  (cardiac  [all
ﬁelds]  and  surgery  [all  ﬁelds])
and
general  anaesthesia  [all  ﬁelds]  or
anesthesia,  general  [Mesh  Terms]  or
(anesthesia  [all  ﬁelds]  and  general  [all
ﬁelds])  or  general  anesthesia  [all  ﬁelds]  or
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ﬁelds])
ariables  of  interest.10 It  is  a  10-item  questionnaire,  in  which
he  ﬁrst  nine  questions  were  used  to  assess  the  search  strat-
gy,  selection  strategy,  quality  used  in  the  review,  data
nalysis  performed,  and  outcomes.  These  questions  were
nswered  with  yes,  no,  or  partial/indeterminate.  The  last
uestion  focused  on  the  systematic  review  overall  scien-
iﬁc  quality  consists  of  a  7-point  scale:  1--2  for  extensive
aws,  2--4  for  major  ﬂaws,  4--6  for  minor  ﬂaws,  and  6--7  for
inimal  ﬂaws.
Only  one  reviewer  assessed  the  methodological  quality  of
ystematic  reviews.  According  to  other  authors  and  to  facil-
tate  interpretation  of  OQAQ  scores,  we  grouped  the  scores
s  follows:  1--2  for  extensive  ﬂaws,  3--4  for  major  ﬂaws,  5--6
or  minor  ﬂaws,  and  7  for  minimal  ﬂaws.11,12 Scores  5--6  were
onsidered  as  systematic  review  of  acceptable  quality  and
 score  of  7  as  good  quality.
The  variables  of  interest  to  this  systematic  review
ere:  mortality,  myocardial  infarction,  stroke,  hospital  stay,
rrhythmia,  and  epidural  hematoma.
This  review  was  not  submitted  to  the  Ethics  Research
ommittee  because  it  is  a  secondary  data  analysis.  The
ethod  used  was  a  convenience  sample.  The  agreement
etween  reviewers  was  assessed  using  the  kappa  statistic.  A
ualitative  approach  was  used  to  evaluate  the  variables  of
nterest  data  reported  in  the  systematic  reviews  found.
esults
he  search  for  systematic  reviews  through  the  analysis  of
itles  and  abstracts  identiﬁed  1469  articles:  622  in  Pubmed,
51  in  Embase,  53  in  Cochrane  Collaboration,  and  143  in
ilacs.  We  excluded  1463  articles  for  not  meeting  inclu-
ion  criteria.  Two  articles  were  excluded  during  the  full
ext  review  for  not  being  systematic  reviews.  Four  system-
tic  reviews  were  selected  for  analysis  of  the  variables  at
he  end  of  the  process.13--16 The  kappa  concordance  index
as  0.75.
c
v
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Table  2  shows  the  frequency  of  responses  to  OQAQ.  After
he  methodological  quality  assessment,  three  systematic
eviews  were  classiﬁed  as  having  minor  ﬂaws13,15,16 and  one
s  having  minimal  ﬂaws.14
Table  3 shows  the  characteristics  of  systematic  reviews
ncluded  for  analysis  of  variables.  There  was  planning  to  ana-
yze  the  epidural  hematoma  variable  in  systematic  reviews,
ut  this  variable  was  not  reported  in  the  randomized  clinical
rials  included  in  these  reviews.
Mortality  was  assessed  in  three  systematic  reviews.  Liu
t  al.13 reported  that  odds  ratio  was  1.56  (95%  CI:  0.35--6.91;
 = 0.56)  for  epidural  anesthesia  and  0.88  (95%  CI:  0.13--5.72;
 = 0.89)  for  spinal  anesthesia.  Zangrillo  et  al.14 reported
hat  the  risk  difference  for  spinal  anesthesia  was  0.00  (95%
I:  −0.02  to  +0.02;  p  = 1.0).  Svircevic  et  al.15 reported  that
elative  risk  for  epidural  anesthesia  was  0.81  (95%  CI:  0.40
o  −1.64;  p  not  provided).
Myocardial  infarction  was  assessed  in  three  systematic
eviews.  Liu  et  al.13 reported  that  odds  ratio  for  epidural
nesthesia  was  0.74  (95%  CI:  0.34--1.59;  p  =  0.44)  and  0.75
95%  CI:  0.24--2.31;  p  =  0.61)  for  spinal  anesthesia.  Zangrillo
t  al.14 reported  that  the  risk  difference  for  spinal  anes-
hesia  was  0.00  (95%  CI:  −0.03  to  +0.02;  p  =  0.77).  Svircevic
t  al.15 reported  that  relative  risk  for  epidural  anesthesia
as  0.80  (95%  CI:  0.52  to  −1.24;  p not  provided).
Stroke  was  e  assessed  in  one  systematic  review.  Svircevic
t  al.15 reported  that  relative  risk  for  epidural  anesthesia
as  0.59  (95%  CI:  0.24  to  −1.46;  p not  provided).
Hospital  stay  was  assessed  in  one  systematic  review.  Zan-
rillo  et  al.14 reported  that  weighted  mean  difference  for
pinal  anesthesia  was  −0.28  days  (95%  CI:  −0.68  to  0.13;
 = 0.18).
Arrhythmia  was  assessed  in  three  systematic  reviews.  Liu
t  al.13 reported  that  odds  ratio  for  epidural  anesthesia  was
.52  (95%  CI:  0.29--0.93;  p  =  0.03)  favorable  to  the  epidu-
al  anesthesia  group.  The  same  beneﬁt  was  not  observed  in
tudies  considering  spinal  anesthesia  with  an  odds  ratio  of
.81  (95%  CI:  0.42--1.53;  p  = 0.51).  Svircevic  et  al.15 demon-
trated  that  relative  risk  for  epidural  anesthesia  was  0.68
95%  CI:  0.50  to  −0.93;  p  not  provided).  Gu  et  al.16 demon-
trated  that  relative  risk  for  epidural  anesthesia  was  0.61
95%  CI:  0.33--1.12;  p  =  0.11).
iscussion
nadequate  pain  control  in  patients  undergoing  cardiac
urgery  may  increase  morbidity  due  to  adverse  hemody-
amic  effects,  increased  metabolic  and  immune  response  to
rauma,  and  hemostatic  abnormalities.17 Aggressive  postop-
rative  pain  management  may  improve  clinical  outcomes  in
igh  risk  patients  undergoing  cardiac  surgery.18 Although  the
dverse  effects  and  the  likelihood  of  prolonged  intubation
nd  mechanical  ventilation  of  opioids  are  known,  the  use  of
ntravenous  opioids  is  a  traditional  choice.17 During  the  last
ecades,  SA  and  TEA  are  gaining  space  in  this  scenario  for
roviding  adequate  analgesia,  even  with  the  knowledge  that
hese  anesthetic  techniques  are  not  without  risks.7Activation  of  cardiac  sympathetic  innervation  causes
oronary  vasoconstriction  and  decreased  response  of  these
essels  to  vasodilation  agents,  changing  the  balance
etween  myocardial  oxygen  supply  and  demand.19 Cardiac
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Table  2  Frequency  of  the  OQAQ  answers.
Topic  for  analysis  Liu  et  al.13 Zangrillo  et  al.14 Svircevic  et  al.15 Gu  et  al.16
1.  Reported  search  methods  No  Yes  Yes  No
2. Comprehensive  search  Undetermined  Yes  Yes  Undetermined
3. Inclusion  criteria  reported  Yes  Yes  Yes  Yes
4. Avoided  selection  bias  Undetermined  Yes  Yes  Undetermined
5. Validity  criteria  reported  Undetermined  Yes  Undetermined  Undetermined
6. Adequately  assessed  validity  Undetermined  Yes  Undetermined  Yes
7. Reported  combined  methods  Yes  Yes  Yes  Yes
8. Combining  results  properly  Yes  Yes  Yes  Yes
Yes
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sympathetic  activation  is  considered  as  a  central  mechanism
for  the  emergence  of  postoperative  myocardial  infarction.19
The  blockade  of  sympathetic  ﬁbers  T1  to  T5  reduces  the
surgical  stress  response,  increases  the  diameter  of  epicar-
dial  stenotic  segments  of  coronary  circulation,  decreases
myocardial  oxygen  consumption,  and  improves  left  ventri-
cular  function.17
SA  can  adequately  reduce  the  surgical  stress  response,
but  the  hemodynamic  changes,  such  as  the  emergence
of  systemic  hypotension  and  bradycardia  associated  with
other  effects  of  total  sympathectomy,  may  bring  harm  to
patients  undergoing  CABG.17 Two  double-blind,  placebo-
controlled  RCTs  attracted  the  attention  of  researchers  for
adequate  analgesia  achieved  with  the  isolated  use  of  neu-
raxial  opioids.20,21 One  of  the  RCTs  reported  that  the  use
of  morphine  0.5  mg  before  induction  of  general  anesthesia
can  reduce  the  time  of  tracheal  intubation  and  decrease  the
duration  of  mechanical  ventilation.20 Although  this  beneﬁ-
cial  effect  may  have  occurred,  it  was  not  found  in  other
studies  and  was  considered  controversial.21--23TEA  can  adequately  reduce  the  surgical  stress  response
and  hemodynamic  changes,  such  as  the  emergence  of  sys-
temic  hypotension  and  bradycardia,  did  not  seem  to  bring
harm  to  patients  undergoing  myocardial  revascularization
t
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Table  3  Characteristics  of  systematic  reviews  included  for  analy
Study  Participants  Intervention  
Liu  et  al.13 Adults,  coronary
insufﬁciency,CPB
GA  +  EA,
GA  +  SA
Zangrillo et  al.14 Adults,  cardiac  surgery  with
or without  CPB,  myocardial
ischemia,  valve
replacement
GA  +  SA  
Svircevic et  al.15 Over  18  years,  cardiac
surgery
GA  +  EA  
Gu et  al.16 Over  18  years,  coronary
insufﬁciency,
CPB,
CPB
GA  +  EA  
n, number of participants; N, numbers of included studies; CPB, cardiopu
SA, spinal anesthesia; ICU, intensive care unit; CVA, cerebrovascular aYes Yes
ith  reports  in  the  literature  of  beta-blockers  dose  reduc-
ion  in  patients  undergoing  CABG.17 Three  RCTs  reported
hat  postoperative  analgesia  is  effective  with  this  tech-
ique;  however,  there  was  divergence  regarding  analgesia
uration,  which  was  different  between  these  studies.24--26
he  common  beneﬁt  among  these  RCTs  was  the  reduced  tra-
heal  intubation  time  and  decreased  mechanical  ventilation
ime.
Systematic  reviews  use  the  available  literature  data  by
ombining  results  from  studies  in  order  to  resolve  conﬂicts
n  medical  knowledge.12 A  systematic  review  cam  improve
he  analysis  statistical  power,  which  cannot  be  achieved  in
rimary  isolated  studies  and  thus  help  to  choose  the  most
ppropriate  interventions  for  populations  of  interest.8 Four
ystematic  reviews  assessing  the  use  of  NA  in  patients  under-
oing  CABG  were  identiﬁed.13--16
A  systematic  review  published  in  2004  assessed  the  use
f  epidural  analgesia  compared  with  intravenous  opioid.13
he  authors  concluded  that  the  use  of  NA  is  favorable,
onsidering  the  time  to  tracheal  extubation,  postopera-
ive  pulmonary  complications,  and  postoperative  cardiac
rrhythmias.  That  review  examined  studies  that  combined
esults  of  patients  who  were  and  who  were  not  undergoing
ardiopulmonary  bypass  (CPB).  The  surgical  stress  cannot  be
sis  of  variables.
Comparison  Variables  n  (N)
GA  Mortality,  heart  attack,
arrhythmias,  pulmonary
complications
1846  (32)
GA  Mortality,  heart  attack,
hospital  stay,  length  of
stay  in  ICU,  arrhythmias,
complications
1106  (25)
GA  Mortality,  heart  attack,
CVA,  supraventricular
tachycardia,  respiratory
complications
2731  (28)
GA  Postoperative  atrial
ﬁbrillation
540  (5)
lmonary bypass; GA, general anesthesia; EA, epidural anesthesia;
ccident.
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he  same  among  patients  who  underwent  CPB  and  those  who
ere  not  submitted  to  CPB  and  this  may  inﬂuence  the  results
hen  combined  in  meta-analysis.  Therefore,  it  would  have
een  more  prudent  if  the  authors  had  analyzed  data  from
wo  types  of  patients  separately.  The  analysis  regarding  the
uality  of  included  studies  was  not  described.  Studies  with
ubious  quality  may  have  been  analyzed  together  with  good
uality  studies  and  affected  meta-analysis  results.
A  systematic  review  published  in  2009  assessed  the  use
A  in  cardiac  surgery.14 The  authors  concluded  that  the
se  of  NA  is  unfavorable  considering  mortality,  myocardial
nfarction,  and  hospital  stay.  That  review  evaluated  stud-
es  in  the  setting  of  cardiac  surgery  and  not  individualized
or  myocardial  revascularization.  Patients  undergoing  heart
alve  surgery  may  have  a  different  postoperative  course
han  those  undergoing  CABG  and  it  is  difﬁcult  to  individu-
lize  the  results.
A systematic  review  published  in  2011  assessed  the  use  of
pidural  analgesia  compared  with  general  anesthesia.15 The
uthors  concluded  that  the  use  of  NA  is  favorable  considering
he  reduced  risk  of  postoperative  supraventricular  arrhyth-
ias  and  respiratory  complications.  That  review  evaluated
tudies  in  cardiac  surgery  setting  and  not  individualized  for
yocardial  revascularization.  The  authors  created  their  own
ool  to  assess  the  methodological  quality  of  the  included
tudies  and  did  not  describe  the  process  of  validation  of  this
ool.  A  non-validated  tool  may  not  accurately  reproduce  the
ariable  of  interest.  Quality  analysis  occurred  for  items  of
nternal  validity  of  randomized  controlled  trials;  however,
he  analysis  could  have  been  more  complete  if  the  items  of
xternal  validity  and  statistical  data  were  also  evaluated.
The  most  recent  systematic  review  was  published  in
012  and  assessed  the  use  of  TEA  compared  with  gen-
ral  anesthesia,16 The  authors  assessed  only  the  presence
f  postoperative  atrial  ﬁbrillation  and  concluded  that  the
se  of  NA  is  not  favorable.  They  reported  the  existence
f  statistical  heterogeneity,  but  did  not  identify  its  origin.
ethodological  quality  analysis  was  done  properly,  but  did
ot  help  to  identify  the  heterogeneity  source.  The  result
f  meta-analysis  with  heterogeneity  should  be  viewed  with
aution  and  may  not  even  be  considered;  however,  it  can
uide  authors  of  future  research  about  the  presence  of  faulty
oints  to  be  avoided.8
The  implications  for  clinical  practice  after  this  system-
tic  review  is  that  the  results  in  the  literature  to  date
hould  be  viewed  with  reservations  and  the  anesthesiol-
gist  should  consider  his  clinical  practice  and  the  care
ffered  by  the  health  service  in  decision  making  regard-
ng  the  patient  undergoing  cardiac  surgery.  The  variables
hat  showed  positive  results  did  not  contribute  to  improve
mportant  clinical  outcomes,  such  as  mortality,  myocardial
nfarction,  stroke,  hospital  stay,  and  even  the  degree  of
atient  satisfaction.  The  identiﬁed  systematic  review  results
ere  contradictory.
The  risk  of  neuraxial  hematoma  was  estimated  by  math-
matical  methods  in  a  study  conducted  in  2000.27 Maximum
isk  after  full  heparinization  was  estimated  at  1:2400  and
euraxial  instrumentation  at  1:1000.  Some  precautions  are
uggested,  such  as  using  neuraxial  technique  when  there
s  laboratory  indication  of  normality  for  coagulation  tests,
elaying  procedures  when  puncture  is  traumatic,  and  wait-
ng  at  least  60  min  after  NA  to  perform  full  heparinization.17
1F.T.  Barbosa  et  al.
The  main  clinical  implication  for  future  research  in  this
linical  setting  refers  to  the  need  for  new  RCTs  with  ade-
uate  statistical  power  and  focusing  on  important  clinical
ariables,  such  as  mortality,  myocardial  infarction,  stroke,
ospital  stay,  arrhythmias,  and  epidural  hematoma.  Sample
ize:  284  participants  are  needed  in  each  group  consider-
ng  1%  mortality  in  neuraxial  anesthesia  group,  5%  mortality
n  general  anesthesia  group,  80%  statistical  power,  and  5%
igniﬁcance  level.
onclusion
he  use  of  neuraxial  anesthesia  in  cardiac  surgery  remains
ontroversial.  The  greatest  beneﬁt  found  by  this  review  was
he  possibility  of  reducing  postoperative  arrhythmias;  how-
ver,  this  beneﬁt  was  contradictory  between  the  identiﬁed
utcomes.  The  outcomes  found  regarding  mortality,  myocar-
ial  infarction,  stroke,  and  hospital  stay  were  not  more
ffective  than  neuraxial  anesthesia.
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